BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 18029019)

  • 1. In vitro antitumour and hepatotoxicity profiles of Au(I) and Ag(I) bidentate pyridyl phosphine complexes and relationships to cellular uptake.
    Liu JJ; Galettis P; Farr A; Maharaj L; Samarasinha H; McGechan AC; Baguley BC; Bowen RJ; Berners-Price SJ; McKeage MJ
    J Inorg Biochem; 2008 Feb; 102(2):303-10. PubMed ID: 18029019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor properties of some 2-[(dimethylamino)methyl]phenylgold(III) complexes.
    Buckley RG; Elsome AM; Fricker SP; Henderson GR; Theobald BR; Parish RV; Howe BP; Kelland LR
    J Med Chem; 1996 Dec; 39(26):5208-14. PubMed ID: 8978849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
    Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C
    J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of toxicity of an experimental bidentate phosphine gold complexed antineoplastic agent in isolated rat hepatocytes.
    Smith PF; Hoke GD; Alberts DW; Bugelski PJ; Lupo S; Mirabelli CK; Rush GF
    J Pharmacol Exp Ther; 1989 Jun; 249(3):944-50. PubMed ID: 2732955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands.
    Santini C; Pellei M; Papini G; Morresi B; Galassi R; Ricci S; Tisato F; Porchia M; Rigobello MP; Gandin V; Marzano C
    J Inorg Biochem; 2011 Feb; 105(2):232-40. PubMed ID: 21194623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, structure and cytotoxicity of triphenylphosphinegold(I) sulfanylpropenoates.
    Barreiro E; Casas JS; Couce MD; Sánchez A; Sánchez-Gonzalez A; Sordo J; Varela JM; Vázquez López EM
    J Inorg Biochem; 2008 Feb; 102(2):184-92. PubMed ID: 17870173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable anticancer gold(III)-porphyrin complexes: effects of porphyrin structure.
    Sun RW; Li CK; Ma DL; Yan JJ; Lok CN; Leung CH; Zhu N; Che CM
    Chemistry; 2010 Mar; 16(10):3097-113. PubMed ID: 20162647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of in vitro cytotoxicity and hepatotoxicity of platinum(II) and palladium(II) oxalato complexes with adenine derivatives as carrier ligands.
    Vrzal R; Starha P; Dvorák Z; Trávnícek Z
    J Inorg Biochem; 2010 Oct; 104(10):1130-2. PubMed ID: 20673688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, structure and cytotoxicity studies of diisopropylammonium and triethylammonium salts of triphenylphosphinegold(I) sulfanylcarboxylates.
    Barreiro E; Casas JS; Couce MD; Sánchez A; Sánchez-González A; Sordo J; Varela JM; López EM
    J Inorg Biochem; 2009 Jul; 103(7):1023-32. PubMed ID: 19501912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of lipophilicity in determining cellular uptake and antitumour activity of gold phosphine complexes.
    McKeage MJ; Berners-Price SJ; Galettis P; Bowen RJ; Brouwer W; Ding L; Zhuang L; Baguley BC
    Cancer Chemother Pharmacol; 2000; 46(5):343-50. PubMed ID: 11127937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand.
    Maiore L; Cinellu MA; Michelucci E; Moneti G; Nobili S; Landini I; Mini E; Guerri A; Gabbiani C; Messori L
    J Inorg Biochem; 2011 Mar; 105(3):348-55. PubMed ID: 21421122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the mechanism of action of platinum(II) complexes with potent cytotoxicity in human cancer cells.
    Krause-Heuer AM; Grünert R; Kühne S; Buczkowska M; Wheate NJ; Le Pevelen DD; Boag LR; Fisher DM; Kasparkova J; Malina J; Bednarski PJ; Brabec V; Aldrich-Wright JR
    J Med Chem; 2009 Sep; 52(17):5474-84. PubMed ID: 19658404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of the mixed phosphine gold species chlorotriphenylphosphine-1,3-bis(diphenylphosphino)propanegold(I).
    Caruso F; Rossi M; Tanski J; Pettinari C; Marchetti F
    J Med Chem; 2003 Apr; 46(9):1737-42. PubMed ID: 12699391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumour activity in non-small cell lung cancer models and toxicity profiles for novel ruthenium(II) based organo-metallic compounds.
    Guichard SM; Else R; Reid E; Zeitlin B; Aird R; Muir M; Dodds M; Fiebig H; Sadler PJ; Jodrell DI
    Biochem Pharmacol; 2006 Feb; 71(4):408-15. PubMed ID: 16360645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, structural characterization, solution behavior, and in vitro antiproliferative properties of a series of gold complexes with 2-(2'-pyridyl)benzimidazole as ligand: comparisons of gold(III) versus gold(I) and mononuclear versus binuclear derivatives.
    Serratrice M; Cinellu MA; Maiore L; Pilo M; Zucca A; Gabbiani C; Guerri A; Landini I; Nobili S; Mini E; Messori L
    Inorg Chem; 2012 Mar; 51(5):3161-71. PubMed ID: 22339487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards the rational design of platinum(II) and gold(III) complexes as antitumour agents.
    Wang X; Guo Z
    Dalton Trans; 2008 Mar; (12):1521-32. PubMed ID: 18335133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stabilization of gold(I) and gold(III) complexes by pyridil bis{3-hexamethylene-iminylthiosemicarbazone}: spectroscopic, structural and computational study.
    Castiñeiras A; Dehnen S; Fuchs A; García-Santos I; Sevillano P
    Dalton Trans; 2009 Apr; (15):2731-9. PubMed ID: 19333496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatin.
    Calamai P; Carotti S; Guerri A; Mazzei T; Messori L; Mini E; Orioli P; Speroni GP
    Anticancer Drug Des; 1998 Jan; 13(1):67-80. PubMed ID: 9474243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large-bite bis(phosphite) ligand containing mesocyclic thioether moieties: synthesis, reactivity, group 11 (Cu(I), Au(I)) metal complexes and anticancer activity studies on a human cervical cancer (HeLa) cell line.
    Suresh D; Balakrishna MS; Rathinasamy K; Panda D; Mague JT
    Dalton Trans; 2008 May; (17):2285-92. PubMed ID: 18414753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.
    Ronconi L; Giovagnini L; Marzano C; Bettìo F; Graziani R; Pilloni G; Fregona D
    Inorg Chem; 2005 Mar; 44(6):1867-81. PubMed ID: 15762713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.